Digg icon reddit icon Stumbleupon icon
Print Email     Print Edition Stories

Wednesday, July 15, 2009

Roush president Tom Taylor to chair MassMEDIC

By Mass High Tech staff

The Massachusetts Medical Device Industry Council (MassMEDIC) reports it has appointed Roush Life Sciences president Tom Taylor to the position of chairman of its board of directors.

Before joining Roush in 2008, Taylor was president of Nypro Life Sciences, a division of plastics manufacturer Nypro Inc. Taylor has also worked as vice president of Millipore Corp.’s OEM health care business unit. In 2007, Taylor traveled to China with Massachusetts Gov. Deval Patrick on a life sciences and clean energy trade mission.

MassMEDIC was established in 1996. The organization has more than 300 members, primarily manufacturers, product developers, suppliers, research institutions and academic health centers.

Roush Life Sciences is a division of Roush Enterprises Inc., whose holdings include product engineering and development supplier Roush Industries, Roush Fenway Racing, Roush Performance Products and Roush Manufacturing. Roush Life Sciences designs and develops laboratory research products and medical devices.








 

Comments

If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.

Digg icon reddit icon Stumbleupon icon
Contact Editor Latest News

Tech Pulse Poll

What's your number one business security priority?



View Results

Stay Informed
Check which newsletter you'd like to receive.
TechFlash (Daily)
BioFlash (Daily)
GreenFlash (Weekly)
Startup Report (Weekly)
Breaking news, MHT events, local announcements
RSS feeds
Your email:

Affiliate publications: ACBJ.com, Boston Business Journal, Bizjournals.com, Portfolio.com, Wired.com

Web Site Developed by Neptune Web, Inc.

Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement and Privacy Policy. About our ads.